title: Chemotherapy-related magnetic resonance imaging abnormalities mimicking disease progression following intraventricular liposomal cytarabine and high dose methotrexate for neurolymphomatosis.
authors.forename: Elena
authors.initials: E
authors.lastname: Pentsova
authors.forename: Marc
authors.initials: M
authors.lastname: Rosenblum
authors.forename: Andrei
authors.initials: A
authors.lastname: Holodny
authors.forename: M Lia
authors.initials: ML
authors.lastname: Palomba
authors.forename: Antonio
authors.initials: A
authors.lastname: Omuro
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001344:Autopsy; D001921:Brain / Q000473:pathology; D001930:Brain Injuries / Q000139:chemically induced; D002699:Chlorambucil / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects*; D018450:Disease Progression; D017809:Fatal Outcome; D006801:Humans; D007278:Injections, Spinal; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000150:complications; D049268:Positron-Emission Tomography / Q000379:methods; D012008:Recurrence; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; D002699:Chlorambucil; D008727:Methotrexate